Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Twinlab/Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Twinlab/Rexall Sundown: Merger discussions between the vitamin/nutritional supplement marketers are terminated, the companies announce Sept. 5. Twinlab and Rexall state that "after several weeks of discussions with the Securities & Exchange Commission," the intended pooling of interests "will not be approved." The proposed merger, which was disclosed by the companies July 1, would have resulted in a firm with combined annual sales of about $400 mil. ("The Tan Sheet" July 7, p. 12)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel